Hiroshi Ohtsu

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 14

Top Topics

Venous Thromboembolism

Positive Breast Cancer

Top Venues

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Scientific reports

Nature medicine

Therapeutic advances in medical oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Takuji Iwase, Shigehira Saji, Kotaro Iijima, Kenji Higaki, Shoichiro Ohtani, Yasuyuki Sato, Yasuo Hozumi, Yoshie Hasegawa, Yasuhiro Yanagita, Hiroyuki Takei, Maki Tanaka, Hideji Masuoka, Masahiko Tanabe, Chiyomi Egawa, Yoshifumi Komoike, Toshitaka Nakamura, Hiroshi Ohtsu, Hirofumi Mukai
Postoperative Adjuvant Anastrozole for 10 or 5 Years in Patients With Hormone Receptor-Positive Breast Cancer: AERAS, a Randomized Multicenter Open-Label Phase III Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Takuji Iwase, Shigehira Saji, Kotaro Iijima, Kenji Higaki, Shoichiro Ohtani, Yasuyuki Sato, Yasuo Hozumi, Yoshie Hasegawa, Yasuhiro Yanagita, Hiroyuki Takei, Maki Tanaka, Hideji Masuoka, Masahiko Tanabe, Chiyomi Egawa, Yoshifumi Komoike, Toshitaka Nakamura, Hiroshi Ohtsu, Hirofumi Mukai
Postoperative Adjuvant Anastrozole for 10 or 5 Years in Patients With Hormone Receptor-Positive Breast Cancer: AERAS, a Randomized Multicenter Open-Label Phase III Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Takuji Iwase, Shigehira Saji, Kotaro Iijima, Kenji Higaki, Shoichiro Ohtani, Yasuyuki Sato, Yasuo Hozumi, Yoshie Hasegawa, Yasuhiro Yanagita, Hiroyuki Takei, Maki Tanaka, Hideji Masuoka, Masahiko Tanabe, Chiyomi Egawa, Yoshifumi Komoike, Toshitaka Nakamura, Hiroshi Ohtsu, Hirofumi Mukai
Postoperative Adjuvant Anastrozole for 10 or 5 Years in Patients With Hormone Receptor-Positive Breast Cancer: AERAS, a Randomized Multicenter Open-Label Phase III Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Mari Terada, Sho Saito, Satoshi Kutsuna, Noriko Kinoshita-Iwamoto, Tomiteru Togano, Akira Hangaishi, Katsuyuki Shiratori, Yuki Takamatsu, Kenji Maeda, Yukihito Ishizaka, Hiroshi Ohtsu, Masahiro Satake, Hiroaki Mitsuya, Norio Ohmagari
Efficacy and Safety of Treatment with Plasma from COVID-19-Recovered Individuals. Life (Basel, Switzerland) 13 (11) (2023)
Takuji Iwase, Shigehira Saji, Kotaro Iijima, Kenji Higaki, Shoichiro Ohtani, Yasuyuki Sato, Yasuo Hozumi, Yoshie Hasegawa, Yasuhiro Yanagita, Hiroyuki Takei, Maki Tanaka, Hideji Masuoka, Masahiko Tanabe, Chiyomi Egawa, Yoshifumi Komoike, Toshitaka Nakamura, Hiroshi Ohtsu, Hirofumi Mukai
Postoperative Adjuvant Anastrozole for 10 or 5 Years in Patients With Hormone Receptor-Positive Breast Cancer: AERAS, a Randomized Multicenter Open-Label Phase III Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Yuki Kimura, Hiroshi Ohtsu, Naohiro Yonemoto, Nobuyoshi Azuma, Kazuhiro Sase
Endovascular versus open repair in patients with abdominal aortic aneurysm: a claims-based data analysis in Japan. BMJ surgery, interventions, & health technologies 4 (1) (2022)
Yukari Tsubata, Takamasa Hotta, Kosuke Hamai, Naoki Furuya, Toshihide Yokoyama, Ryota Saito, Atsushi Nakamura, Takeshi Masuda, Megumi Hamaguchi, Shoichi Kuyama, Ryoichi Honda, Tadashi Senoo, Masamoto Nakanishi, Masahiro Yamasaki, Nobuhisa Ishikawa, Kazunori Fujitaka, Tetsuya Kubota, Hiroshi Ohtsu, Kunihiko Kobayashi, Takeshi Isobe
Incidence of venous thromboembolism in advanced lung cancer and efficacy and safety of direct oral anticoagulants: a multicenter, prospective, observational study (Rising-VTE/NEJ037 study). Therapeutic advances in medical oncology 14 (2022)
Hiroshi Ohtsu, Akihiko Shimomura, Sakiko Miyazaki, Naohiro Yonemoto, Shinichiro Ueda, Chikako Shimizu, Kazuhiro Sase
Cardiotoxicity of adjuvant chemotherapy with trastuzumab: a Japanese claim-based data analysis. Open heart 9 (2) (2022)
Tomoki Todo, Hirotaka Ito, Yasushi Ino, Hiroshi Ohtsu, Yasunori Ota, Junji Shibahara, Minoru Tanaka
Intratumoral oncolytic herpes virus G47∆ for residual or recurrent glioblastoma: a phase 2 trial. Nature medicine 28 (8) (2022)
Tomoki Todo, Yasushi Ino, Hiroshi Ohtsu, Junji Shibahara, Minoru Tanaka
A phase I/II study of triple-mutated oncolytic herpes virus G47∆ in patients with progressive glioblastoma. Nature communications 13 (1) (2022)
Mari Terada, Hiroshi Ohtsu, Sho Saito, Kayoko Hayakawa, Shinya Tsuzuki, Yusuke Asai, Nobuaki Matsunaga, Satoshi Kutsuna, Wataru Sugiura, Norio Ohmagari
Risk factors for severity on admission and the disease progression during hospitalisation in a large cohort of patients with COVID-19 in Japan. BMJ open 11 (6) (2021)
Dai Miyazaki, Kazumi Fukagawa, Atsuki Fukushima, Hiroshi Fujishima, Eiichi Uchio, Nobuyuki Ebihara, Jun Shoji, Etsuko Takamura, Kenichi Namba, Yuichi Ohashi, Shigeki Okamoto, Yoshiyuki Satake, Hiroshi Ohtsu, Yumiko Shimizu, Yoshitsugu Inoue
Air pollution significantly associated with severe ocular allergic inflammatory diseases. Scientific reports 9 (1) (2019)
Hyun Seok Lee, Seong Woo Jeon, Sachiyo Nomura, Yasuyuki Seto, Yong Hwan Kwon, Su Youn Nam, Yuko Ishibashi, Hiroshi Ohtsu, Yasukazu Ohmoto, Hae Min Yang
Screening Biomarker as an Alternative to Endoscopy for the Detection of Early Gastric Cancer: The Combination of Serum Trefoil Factor Family 3 and Pepsinogen. Gastroenterology research and practice 2018 (2018)
Yuko Ishibashi, Hiroshi Ohtsu, Masako Ikemura, Yasuko Kikuchi, Takayoshi Niwa, Kotoe Nishioka, Yoshihiro Uchida, Hirona Miura, Susumu Aikou, Toshiaki Gunji, Nobuyuki Matsuhashi, Yasukazu Ohmoto, Takeshi Sasaki, Yasuyuki Seto, Toshihisa Ogawa, Keiichiro Tada, Sachiyo Nomura
Serum TFF1 and TFF3 but not TFF2 are higher in women with breast cancer than in women without breast cancer. Scientific reports 7 (1) (2017)